![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
General American Investors Company Inc | NYSE:GAM-B | NYSE | Preference Share |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.87 | 0 | 09:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-00041 | ||
GENERAL AMERICAN INVESTORS COMPANY, INC. | ||
(Exact name of registrant as specified in charter) | ||
530 Fifth Avenue, 26th Floor, New York, New York 10036 | ||
(Address of principal executive offices) (Zip code) |
Eugene S. Stark
General American Investors Company, Inc.
530 Fifth Avenue
26th Floor
New York, New York 10036
(Name and address of agent for service)
Copy to:
John E. Baumgardner, Jr., Esq.
Sullivan & Cromwell LLP
125 Broad Street
New York, New York 10004
Registrant's telephone number, including area code: 212-916-8400
Date of fiscal year end: December 31
Date of reporting period: June 30, 2021
TO THE STOCKHOLDERS |
|
F
or the six months ended June 30, 2021, return as measured based upon net asset value (NAV) per common share, including reinvestment of dividends and distributions, was 16.11% while the investment return to our stockholders (based upon market price per share), also including reinvestment of dividends and distributions, was 17.50%. By comparison, the return for our benchmark, the Standard and Poor’s 500 Stock Index (including income), was 15.25% during this period. For the twelve months ended June 30, 2021, return on net asset value was 41.67% and return to our stockholders was 46.66% which compares to the return of the S&P 500 Stock Index of 40.79%. During both time periods, the discount at which our shares traded continued to fluctuate and on June 30, 2021 it was 14.46%.
As detailed in the accompanying financial statements (unaudited), as of June 30, 2021, the net assets applicable to the Company’s Common Stock were $1,227,414,148 equal to $50.76 per Common Share.
The increase in net assets resulting from operations for the six months ended June 30, 2021 was $167,403,668. During this period, the net realized gain on investments was $51,684,338 and the increase in net unrealized appreciation was $120,606,112. Net investment income for the six months was $769,204. Distributions to preferred and common shareholders amounted to $5,655,986 and $6,149,060, respectively. During the six months, the Company also repurchased 546,332 of its shares at a cost of $21,811,523, an average discount to net asset value of 14.6%.
The U.S. and world equity markets performed well in the second quarter as economies continued to expand rapidly thanks to broadening distribution of vaccines. As well, evidence that the vaccines also work against a number of variants amid U.S. households flush with government stimulus checks, a high savings rate, improved employment prospects and high consumer confidence have accelerated consumption. As inventories of a variety of goods and the available supply of services declined during the pandemic, prices have adjusted upward to reflect the new reality of shortages. Limited availability of semiconductors, furthermore, have led to downstream production shortfalls for autos, dishwashers, refrigerators, consumer electronics and a myriad of other goods. Services including travel bookings, restaurant reservations, and events all have reduced capacity and are experiencing price increases, some significant. And while some will surely fade as capacity expands and supply chains improve, many may not. Expected transitory price
increases may linger for longer as wages are pushed higher amidst elevated quit rates, a deficit of available workers and rapidly expanding job listings. Some of these imbalances may be policy related as government transfer payments exceed pay for many workers, leaving some with incentive to defer employment. In conjunction with continued expansive fiscal policy reflected in upcoming government spending packages and thus far, an acquiescent Federal Reserve, near term growth prospects continue to appear robust, albeit potentially at a decelerating pace.
In sum, a significant amount of excess liquidity still exists in the U.S. and developed economies including nearly $5 trillion, or roughly 23% of U.S. Gross Domestic Product, in money market accounts, likely providing significant support to markets, notwithstanding the possibility of corrections that are typical of bull markets. And though monetary policy may be on the verge of a shift, fiscal policy, if recent proposals are taken at face value, could overwhelm the speculated tightening. Earnings may continue their elevated growth rates, albeit decelerating, while earnings multiples may appear to be stretched. While interest rates remain low, income and investment tax policy represent a potentially significant drag for taxable investors and corporations, particularly when joined with higher inflation and its associated eventual tax bracket creep. Margins, though expanding off the bottom of a Covid related contraction, seem to be at some risk to rising input prices. Thus, equity valuations appear fair and perhaps full, leaving little room for company disappointments or policy error. On the whole, equities seem relatively better positioned for inflation and continued robust growth. The bond market’s recent behavior, however, does suggest some caution is warranted.
Information about the Company, including our investment objectives, operating policies and procedures, investment results, record of dividend and distribution payments, financial reports, and press releases, is on our website and has been updated through June 30, 2021. It can be accessed on the internet at www.generalamericaninvestors.com.
By Order of the Board of Directors,
General American Investors Company, Inc.
Jeffrey W. Priest
President and Chief Executive Officer
July 28, 2021
2 |
|
STATEMENT OF INVESTMENTS June 30, 2021 (Unaudited) |
General American Investors |
3 |
|
STATEMENT OF INVESTMENTS June 30, 2021 (Unaudited) - continued |
General American Investors |
|
|
Shares |
|
COMMON STOCKS (continued) |
|
|
Value
|
|
Financials
|
|
Diversified Financials (6.0%) |
|
|||||
|
110 |
|
Berkshire Hathaway Inc. - Class A (a)(b) |
|
|
$46,046,110
|
|
|
|
31,549 |
|
Berkshire Hathaway Inc. - Class B (a) |
|
|
8,768,098 |
|
|
|
243,415 |
|
Nelnet, Inc. |
|
|
18,312,110 |
|
|
|
|
|
|
(Cost $9,498,918) |
|
73,126,318 |
|
|
|
|
Insurance (7.7%) |
|
|||||
|
|
856,828 |
|
Arch Capital Group Ltd. (a) (Bermuda) |
|
|
33,364,882 |
|
|
|
250,000 |
|
Axis Capital Holdings Limited (Bermuda) |
|
|
12,252,500 |
|
|
|
121,500 |
|
Everest Re Group, Ltd. (Bermuda) |
|
|
30,619,215 |
|
|
|
316,927 |
|
MetLife, Inc. |
|
|
18,968,081 |
|
|
|
|
|
|
(Cost $28,961,538) |
|
95,204,678 |
|
|
|
|
|
|
(Cost $41,700,449) |
|
196,758,296 |
|
|
|
|
|
|
|
|
|
|
Health Care
|
|
Health Care Equipment and Services (0.6%) |
|
|||||
62,000 |
|
Abbott Laboratories |
(Cost $5,079,301) |
|
7,187,660 |
|
||
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology and Life Sciences (7.3%) |
|
|||||
|
|
100,900 |
|
Gilead Sciences, Inc. |
|
|
6,947,974 |
|
|
|
350,804 |
|
Intra-Cellular Therapies, Inc. (a) |
|
|
14,319,819 |
|
|
|
76,471 |
|
Kindred Biosciences, Inc. (a) |
|
|
701,239 |
|
|
|
245,191 |
|
Merck & Co., Inc. |
|
|
19,068,504 |
|
|
|
1,041,197 |
|
Paratek Pharmaceuticals, Inc. (a) |
|
|
7,100,964 |
|
|
|
365,808 |
|
Pfizer Inc. |
|
|
14,325,041 |
|
|
|
13,001 |
|
Regeneron Pharmaceuticals, Inc. (a) |
|
|
7,261,579 |
|
|
|
850,000 |
|
Valneva SE (a) (France) |
|
|
11,227,868 |
|
|
|
75,000 |
|
Valneva SE ADS (a) (France) |
|
|
1,976,250 |
|
|
|
1,877,497 |
|
VBI Vaccines, Inc. (a) (Canada) |
|
|
6,289,615 |
|
|
|
|
|
|
(Cost $51,702,557) |
|
89,218,853 |
|
|
|
|
|
|
(Cost $56,781,858) |
|
96,406,513 |
|
|
|
|
|
|
|
|
|
|
Industrials
|
|
Capital Goods (3.0%) |
|
|||||
146,131 |
|
Eaton Corporation plc (Ireland) |
|
|
21,653,692 |
|
||
|
|
175,000 |
|
Raytheon Technologies Corporation |
|
|
14,929,250 |
|
|
|
|
|
|
(Cost $17,272,799) |
|
36,582,942 |
|
|
|
Commercial and Professional Services (6.0%) |
|
|||||
|
|
189,085 |
|
Otis Worldwide Corporation |
|
|
15,461,480 |
|
|
|
524,895 |
|
Republic Services, Inc. |
|
|
57,743,699 |
|
|
|
|
|
|
(Cost $17,016,794) |
|
73,205,179 |
|
|
|
|
|
|
(Cost $34,289,593) |
|
109,788,121 |
|
|
|
|
|
|
|
|
|
|
Information
|
|
Semiconductors and Semiconductor Equipment (9.7%) |
|
|||||
333,364 |
|
AIXTRON SE (a) (Germany) |
|
|
9,032,294 |
|
||
131,652 |
|
Applied Materials, Inc. |
|
|
18,747,245 |
|
||
|
|
82,850 |
|
ASML Holding N.V. (Netherlands) |
|
|
57,236,094 |
|
|
|
26,000 |
|
Broadcom Inc. |
|
|
12,397,840 |
|
|
|
115,000 |
|
Intel Corporation |
|
|
6,456,100 |
|
|
|
68,009 |
|
Universal Display Corporation |
|
|
15,120,441 |
|
|
|
|
|
|
(Cost $35,139,085) |
|
118,990,014 |
|
4 |
|
STATEMENT OF INVESTMENTS June 30, 2021 (Unaudited) - continued |
General American Investors |
(see notes to unaudited financial statements)
|
|
Shares |
|
COMMON STOCKS (continued) |
|
|
Value
|
|
Information
|
|
Software and Services (11.0%) |
|
|||||
|
92,653 |
|
Akamai Technologies, Inc. (a) |
|
|
$10,803,340
|
|
|
|
43,000 |
|
Autodesk, Inc. (a) |
|
|
12,551,700 |
|
|
|
104,101 |
|
Citrix Systems, Inc. |
|
|
12,207,924 |
|
|
|
115,000 |
|
Fiserv, Inc. (a) |
|
|
12,292,350 |
|
|
|
235,000 |
|
Microsoft Corporation |
|
|
63,661,500 |
|
|
|
350,000 |
|
Nuance Communications, Inc. (a) |
|
|
19,054,000 |
|
|
|
11,000 |
|
Tyler Technologies, Inc. (a) |
|
|
4,976,070 |
|
|
|
|
|
|
(Cost $66,105,381) |
|
135,546,884 |
|
|
|
|
Technology, Hardware and Equipment (6.2%) |
|
|||||
|
|
348,000 |
|
Apple Inc. |
|
|
47,662,080 |
|
|
|
525,000 |
|
Cisco Systems, Inc. |
|
|
27,825,000 |
|
|
|
|
|
|
(Cost $10,176,168) |
|
75,487,080 |
|
|
|
|
|
|
(Cost $111,420,634) |
|
330,023,978 |
|
|
|
|
|
|
|
|
|
|
Materials (3.0%) |
|
157,554 |
|
Agnico Eagle Mines Limited (Canada) |
|
|
9,524,139 |
|
|
|
380,300 |
|
Barrick Gold Corporation (Canada) |
|
|
7,864,604 |
|
|
|
644,669 |
|
Cleveland-Cliffs Inc. (a) |
|
|
13,899,064 |
|
|
|
28,752 |
|
Rogers Corporation (a) |
|
|
5,773,402 |
|
|
|
|
|
|
(Cost $29,066,194) |
|
37,061,209 |
|
|
|
|
|
|
|
|
|
|
Miscellanous (1.6%) |
|
1,958,438 |
|
Other (c) |
(Cost $17,636,887) |
|
19,828,238 |
|
|
||||||||
|
|
|
|
TOTAL COMMON STOCKS (104.4%) |
(Cost $489,775,961) |
|
1,281,285,133 |
|
|
||||||||
|
|
Rights |
|
Rights (a) |
|
|
|
|
Pharmaceuticals,
|
|
1,415,824 |
|
Elanco Animal Health Incorporated/December 31, 2021/$0.25 |
(Cost $35,646) |
|
— |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
Options (a) |
|
|
|
|
Call Options |
|
Contracts
|
|
Company/Expiration Date/Exercise Price/Notional |
|
|||
Pharmaceuticals,
|
|
1,099 |
|
Vaxart, Inc./July 16, 2021/$7.50/$824,250 |
(Cost $80,911) |
|
71,435 |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
Shares |
|
SHORT-TERM SECURITY AND OTHER ASSETS |
|
|
|
|
|
|
154,810,707 |
|
State Street Institutional Treasury Plus Money Market Fund, |
|
|
|
|
|
|
|
|
Trust Class, 0.01% (d) (12.6%) |
(Cost $154,810,707) |
|
154,810,707 |
|
|
||||||||
TOTAL INVESTMENTS (e) (117.0%) |
(Cost $644,703,225) |
|
1,436,167,275 |
|
||||
Liabilities in excess of other assets (-1.5%) |
|
|
(18,635,952 |
) |
||||
|
|
|
|
|
|
|
1,417,531,323 |
|
PREFERRED STOCK (-15.5%) |
|
(190,117,175 |
) |
|||||
NET ASSETS APPLICABLE TO COMMON STOCK (100%) |
|
$1,227,414,148
|
|
ADR - American Depository Receipt
ADS - American Depository Shares
(a)Non-income producing security.
(b)50 shares of 110 total shares held as collateral for options written.
(c)Securities which have been held for less than one year, not previously disclosed, and not restricted.
(d)7-day yield.
(e)At June 30, 2021, the cost of investments and derivatives for Federal income tax purposes was $645,214,399; aggregate gross unrealized appreciation was $801,158,219; aggregate gross unrealized depreciation was $9,343,305; and net unrealized appreciation was $791,814,914.
5 |
|
STATEMENT OF OPTIONS WRITTEN June 30, 2021 (Unaudited) |
General American Investors |
(see notes to unaudited financial statements)
Call Options |
|
Contracts
|
|
Company/Expiration Date/Exercise Price/Notional |
Premiums
|
|
Value
|
|
Materials (0.0%) |
|
500 |
|
Cleveland-Cliffs Inc./July 16, 2021/$22/$1,100,000 |
$67,650
|
|
$49,500
|
|
|
|
1,500 |
|
Cleveland-Cliffs Inc./July 16, 2021/$23/$3,450,000 |
526,821 |
|
103,500 |
|
|
|
|
|
|
594,471 |
|
153,000 |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals,
|
|
500 |
|
Vaxart, Inc./July 16, 2021/$12.50/$625,000 |
54,819 |
|
12,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors and
|
|
1,100 |
|
Intel Corporation/July 16, 2021/$57.50/$6,325,000 |
201,261 |
|
67,100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL CALL OPTIONS (0.0%) |
850,551 |
|
232,100 |
|
|
|
|
|
|
|
|
|
|
|
Put Options |
|
|
|
|
|
|
|
|
Media and Entertainment
|
|
2,700 |
|
ANGI Inc./August 20, 2021/$15/$4,050,000 |
816,169 |
|
607,500 |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals,
|
|
395 |
|
Vaxart, Inc./July 16, 2021/$5/$197,500 |
37,288 |
|
2,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PUT OPTIONS (0.1%) |
853,457 |
|
609,870 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL OPTIONS WRITTEN (0.1%) |
$1,704,008
|
|
$841,970
|
|
*The maximum cash outlay if all options are exercised is $15,747,500.
6 |
|
MAJOR STOCK CHANGES (a): Three Months Ended June 30, 2021 (Unaudited) |
General American Investors |
(see notes to unaudited financial statements)
Increases |
|
Net Shares
|
|
Shares
|
|
New Positions |
|
|
|
|
|
Advance Auto Parts, Inc. |
|
37,761 |
|
37,761 |
|
Autodesk, Inc. |
|
43,000 |
|
43,000 |
|
Broadcom Inc. |
|
26,000 |
|
26,000 |
|
Fiserv, Inc |
|
115,000 |
|
115,000 |
|
Intel Corporation |
|
115,000 |
|
115,000 |
|
Regeneron Pharmaceuticals, Inc. |
|
1,500 |
|
13,001 |
(b) |
Rogers Corporation |
|
3,841 |
|
28,752 |
(b) |
Valneva SE ADS |
|
75,000 |
|
75,000 |
|
|
|
|
|
|
|
Additions |
|
|
|
|
|
Agnico Eagle Mines Limited |
|
25,000 |
|
157,554 |
|
AIXTRON SE |
|
40,000 |
|
333,364 |
|
Chevron Corporation |
|
19,164 |
|
96,991 |
|
Citrix Systems, Inc. |
|
29,000 |
|
104,101 |
|
Intra-Cellular Therapies, Inc. |
|
3,307 |
|
350,804 |
|
Nuance Communications, Inc. |
|
100,000 |
|
350,000 |
|
Paratek Pharmaceuticals, Inc. |
|
54,602 |
|
1,041,197 |
|
T-Mobile US, Inc. |
|
10,000 |
|
202,950 |
|
VBI Vaccines, Inc. |
|
50,000 |
|
1,877,497 |
|
|
|
|
|
|
|
Decreases |
|||||
Eliminations |
|
|
|
|
|
Biohaven Pharmaceutical Holding Company Ltd. |
|
45,000 |
|
— |
|
Helix Energy Solutions Group, Inc. |
|
350,000 |
|
— |
|
Lumentum Holdings Inc. |
|
95,000 |
|
— |
|
|
|
|
|
|
|
Reductions |
|
|
|
|
|
Apple Inc. |
|
10,000 |
|
348,000 |
|
Applied Materials, Inc. |
|
10,000 |
|
131,652 |
|
ASML Holding N.V. |
|
3,000 |
|
82,850 |
|
Berkshire Hathaway Inc. - Class B |
|
5,000 |
|
31,549 |
|
Cleveland-Cliffs Inc. |
|
55,000 |
|
644,669 |
|
Diageo plc ADR |
|
15,810 |
|
25,000 |
|
Energy Transfer LP |
|
176,404 |
|
1,050,030 |
|
Kindred Biosciences, Inc. |
|
208,529 |
|
76,471 |
|
Microsoft Corporation |
|
10,000 |
|
235,000 |
|
Pfizer Inc. |
|
25,000 |
|
365,808 |
|
Raytheon Technologies Corporation |
|
42,541 |
|
175,000 |
|
Republic Services, Inc. |
|
38,000 |
|
524,895 |
|
Walmart Inc. |
|
35,000 |
|
65,140 |
|
(a)Common shares unless otherwise noted.
(b)Shares purchased in prior period and previously carried under Common Stocks - Miscellaneous - Other.
7 |
|
PORTFOLIO DIVERSIFICATION June 30, 2021 (Unaudited) |
General American Investors |
(see notes to unaudited financial statements)
The diversification of the Company’s net assets applicable to its Common Stock by industry group as of June 30, 2021 is shown in the table.
Industry Category |
|
Cost
|
|
Value
|
|
|
Percent Common
|
|||
Information Technology |
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment |
|
$35,139
|
|
$118,990
|
|
|
|
9.7 |
% |
|
Software & Services |
|
66,105 |
|
135,547 |
|
|
|
11.0 |
|
|
Technology, Hardware & Equipment |
|
10,176 |
|
75,487 |
|
|
|
6.2 |
|
|
|
|
111,420 |
|
330,024 |
|
|
|
26.9 |
|
|
Financials |
|
|
|
|
|
|
|
|
|
|
Banks |
|
3,240 |
|
28,427 |
|
|
|
2.3 |
|
|
Diversified Financials |
|
9,499 |
|
73,126 |
|
|
|
6.0 |
|
|
Insurance |
|
28,961 |
|
95,205 |
|
|
|
7.7 |
|
|
|
|
41,700 |
|
196,758 |
|
|
|
16.0 |
|
|
Communication Services |
|
|
|
|
|
|
|
|
|
|
Media & Entertainment |
|
50,474 |
|
127,674 |
|
|
|
10.4 |
|
|
Telecommunication Services |
|
22,888 |
|
29,393 |
|
|
|
2.4 |
|
|
|
|
73,362 |
|
157,067 |
|
|
|
12.8 |
|
|
Consumer Discretionary |
|
|
|
|
|
|
|
|
|
|
Automobiles & Components |
|
9,176 |
|
9,122 |
|
|
|
0.8 |
|
|
Retailing |
|
43,130 |
|
145,143 |
|
|
|
11.8 |
|
|
|
|
52,306 |
|
154,265 |
|
|
|
12.6 |
|
|
Consumer Staples |
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco |
|
23,203 |
|
73,056 |
|
|
|
6.0 |
|
|
Food & Staples Retailing |
|
10,412 |
|
34,905 |
|
|
|
2.8 |
|
|
Household & Personal Products |
|
15,024 |
|
31,023 |
|
|
|
2.5 |
|
|
|
|
48,639 |
|
138,984 |
|
|
|
11.3 |
|
|
Industrials |
|
|
|
|
|
|
|
|
|
|
Capital Goods |
|
17,273 |
|
36,583 |
|
|
|
3.0 |
|
|
Commercial & Professional Services |
|
17,017 |
|
73,205 |
|
|
|
6.0 |
|
|
|
|
34,290 |
|
109,788 |
|
|
|
9.0 |
|
|
Health Care |
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services |
|
5,079 |
|
7,188 |
|
|
|
0.6 |
|
|
Pharmaceuticals, Biotechnology & Life Sciences |
|
51,819 |
|
89,290 |
|
|
|
7.3 |
|
|
|
|
56,898 |
|
96,478 |
|
|
|
7.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy |
|
24,574 |
|
41,103 |
|
|
|
3.3 |
|
|
Materials |
|
29,066 |
|
37,061 |
|
|
|
3.0 |
|
|
Miscellaneous** |
|
17,637 |
|
19,828 |
|
|
|
1.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
489,892 |
|
1,281,356 |
|
|
|
104.4 |
|
|
Short-Term Securities |
|
154,811 |
|
154,811 |
|
|
|
12.6 |
|
|
Total Investments |
|
$644,703
|
|
1,436,167 |
|
|
|
117.0 |
|
|
Liabilities in Excess of Other Assets |
|
|
|
(18,636 |
) |
|
|
(1.5 |
) |
|
Preferred Stock |
|
|
|
(190,117 |
) |
|
|
(15.5 |
) |
|
Net Assets Applicable to Common Stock |
|
|
|
$1,227,414
|
|
|
|
100.0 |
% |
|
*Net Assets applicable to the Company’s Common Stock
**Securities which have been held for less than one year, not previously disclosed, and not restricted.
8 |
|
STATEMENT OF ASSETS AND LIABILITIES June 30, 2021 (Unaudited) |
General American Investors |
(see notes to unaudited financial statements)
Assets |
||||
INVESTMENTS, AT VALUE (NOTE 1a) |
|
|
|
|
Common stocks (cost $489,775,961) |
|
|
|
$1,281,285,133
|
Rights (cost $35,646) |
|
|
|
— |
Purchased options (cost $80,911; note 4) |
|
|
|
71,435 |
Money market fund (cost $154,810,707) |
|
|
|
154,810,707 |
|
||||
Total investments (cost $644,703,225) |
|
|
|
1,436,167,275 |
|
||||
OTHER ASSETS |
|
|
|
|
Receivable for securities sold |
|
$5,944,387
|
|
|
Dividends, interest and other receivables |
|
1,159,876 |
|
|
Present value of future office lease payments (note 8) |
|
4,279,633 |
|
|
Qualified pension plan asset, net excess funded (note 7) |
|
5,431,912 |
|
|
Prepaid expenses, fixed assets, and other assets |
|
1,134,385 |
|
17,950,193 |
|
||||
TOTAL ASSETS |
|
|
|
1,454,117,468 |
|
||||
Liabilities |
||||
Payable for securities purchased |
|
15,331,919 |
|
|
Accrued preferred stock dividend not yet declared |
|
219,955 |
|
|
Outstanding options written, at value (premiums received $1,704,008; note 4) |
|
841,970 |
|
|
Accrued compensation payable to officers and employees |
|
1,983,563 |
|
|
Present value of future office lease payments (note 8) |
|
4,279,633 |
|
|
Accrued supplemental pension plan liability (note 7) |
|
6,987,190 |
|
|
Accrued supplemental thrift plan liability (note 7) |
|
6,457,666 |
|
|
Accrued expenses and other liabilities |
|
484,249 |
|
|
|
||||
TOTAL LIABILITIES |
|
|
|
36,586,145 |
|
||||
5.95% CUMULATIVE PREFERRED STOCK, SERIES B - |
|
|
|
|
7,604,687 shares at a liquidation value of $25 per share (note 5) |
|
|
|
190,117,175 |
|
||||
NET ASSETS APPLICABLE TO COMMON STOCK - 24,181,874 shares (note 5) |
|
|
|
$1,227,414,148
|
|
||||
NET ASSET VALUE PER COMMON SHARE |
|
|
|
$50.76
|
|
||||
Net Assets Applicable to Common Stock |
||||
Common Stock, 24,181,874 shares at par value (note 5) |
|
$24,181,874
|
|
|
Additional paid-in capital (note 5) |
|
369,421,814 |
|
|
Unallocated distributions on Preferred Stock |
|
(5,875,941 |
) |
|
Total distributable earnings (note 5) |
|
843,072,284 |
|
|
Accumulated other comprehensive loss (note 7) |
|
(3,385,883 |
) |
|
|
||||
NET ASSETS APPLICABLE TO COMMON STOCK |
|
|
|
$1,227,414,148
|
9 |
|
STATEMENT OF OPERATIONS Six Months Ended June 30, 2021 (Unaudited) |
General American Investors |
(see notes to unaudited financial statements)
Income |
|
||||
Dividends (net of foreign withholding taxes of $259,300) |
|
|
|
$8,186,286
|
|
Interest |
|
|
|
7,809 |
|
|
|
|
|
8,194,095 |
|
|
|||||
Expenses |
|
||||
Investment research |
|
$4,520,860
|
|
|
|
Administration and operations |
|
1,856,231 |
|
|
|
Office space and general |
|
502,837 |
|
|
|
Transfer agent, custodian, and registrar fees and expenses |
|
165,235 |
|
|
|
Auditing and legal fees |
|
148,766 |
|
|
|
Directors’ fees and expenses |
|
106,493 |
|
|
|
State and local taxes |
|
75,872 |
|
|
|
Stockholders’ meeting and reports |
|
48,597 |
|
7,424,891 |
|
NET INVESTMENT INCOME |
|
|
|
769,204 |
|
|
|||||
Realized Gain and Change In Unrealized Appreciation on Investments (Notes 1, 3 and 4) |
|
||||
Net realized gain on investments: |
|
|
|
|
|
Common stock |
|
51,053,228 |
|
|
|
Purchased options |
|
(104,025 |
) |
|
|
Written options |
|
735,135 |
|
|
|
|
|
51,684,338 |
|
|
|
Net increase in unrealized appreciation: |
|
|
|
|
|
Common stocks and rights |
|
118,376,909 |
|
|
|
Purchased options |
|
475,199 |
|
|
|
Written options |
|
1,754,004 |
|
|
|
|
|
120,606,112 |
|
|
|
GAINS AND APPRECIATION ON INVESTMENTS |
|
|
|
172,290,450 |
|
NET INVESTMENT INCOME, GAINS, AND APPRECIATION ON INVESTMENTS |
|
|
|
173,059,654 |
|
DISTRIBUTIONS TO PREFERRED STOCKHOLDERS |
|
|
|
(5,655,986 |
) |
INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
|
|
|
$167,403,668
|
|
STATEMENTS OF CHANGES IN NET ASSETS
Operations |
|
Six Months Ended
|
|
Year Ended
|
|
|
Net investment income |
|
$769,204
|
|
|
$3,134,606
|
|
Net realized gain on investments |
|
51,684,338 |
|
|
74,962,718 |
|
Net increase (decrease) in unrealized appreciation |
|
120,606,112 |
|
|
(1,125,262 |
) |
|
|
173,059,654 |
|
|
76,972,062 |
|
|
||||||
Distributions to Preferred Stockholders |
|
(5,655,986 |
) |
|
(11,311,972 |
) |
INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
|
167,403,668 |
|
|
65,660,090 |
|
OTHER COMPREHENSIVE INCOME |
|
|
|
|
|
|
Funded status of defined benefit plans (note 7) |
|
— |
|
|
803,084 |
|
|
||||||
Distributions to Common Stockholders |
|
(6,149,060 |
) |
|
(60,588,552 |
) |
|
||||||
Capital Share Transactions (Note 5) |
|
|||||
Value of Common Shares issued in payment of dividends and distributions |
|
— |
|
|
26,713,960 |
|
Cost of Common Shares purchased |
|
(21,811,523 |
) |
|
(26,315,133 |
) |
INCREASE (DECREASE) IN NET ASSETS - CAPITAL TRANSACTIONS |
|
(21,811,523 |
) |
|
398,827 |
|
NET INCREASE IN NET ASSETS |
|
139,443,085 |
|
|
6,273,449 |
|
|
||||||
Net Assets Applicable to Common Stock |
|
|||||
BEGINNING OF PERIOD |
|
1,087,971,063 |
|
|
1,081,697,614 |
|
END OF PERIOD |
|
$1,227,414,148
|
|
|
$1,087,971,063
|
|
10 |
|
FINANCIAL HIGHLIGHTS |
General American Investors |
(see notes to unaudited financial statements)
The following table shows per share operating performance data, total investment return, ratios, and supplemental data for the six months ended June 30, 2021 and for each year in the five-year period ended December 31, 2020. This information has been derived from information contained in the financial statements and market price data for the Company’s shares.
*Not annualized
**Annualized
11 |
|
NOTES TO FINANCIAL STATEMENTS (Unaudited) |
General American Investors |
1. Significant Accounting Policies and Other Matters – General American Investors Company, Inc. (the “Company”), established in 1927, is registered under the Investment Company Act of 1940 as a closed-end, diversified management investment company. It is internally managed by its officers under the direction of the Board of Directors.
The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) pursuant to the requirements for reporting; Accounting Standards Codification 946, Financial Services – Investment Companies (“ASC 946”), and Regulation S-X.
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income, expenses, and gains and losses during the reported period. Changes in the economic environment, financial markets, and any other parameters used in determining these estimates could cause actual results to differ, and these differences could be material.
a.Security Valuation Equity securities traded on a national securities exchange are valued at the last reported sales price on the last business day of the period. Equity securities reported on the NASDAQ national market are valued at the official closing price on that day. Listed and NASDAQ equity securities for which no sales are reported on that day and other securities traded in the over-the-counter market are valued at the last bid price (asked price for options written) on the valuation date. Equity securities traded primarily in foreign markets are valued at the closing price of such securities on their respective exchanges or markets. Corporate debt securities, domestic and foreign, are generally traded in the over-the-counter market rather than on a securities exchange. The Company utilizes the latest bid prices provided by independent dealers and information with respect to transactions in such securities to determine current market value. If, after the close of foreign markets, conditions change significantly, the price of certain foreign securities may be adjusted to reflect fair value as of the time of the valuation of the portfolio. Investments in money market funds are valued at their net asset value.
b.Options The Company may purchase and write (sell) put and call options. The Company purchases put options or writes call options to hedge the value of portfolio investments while it purchases call options and writes put options to obtain equity market exposure. The risk associated with purchasing an option is that the Company pays a premium whether or not the option is exercised. Additionally, the Company bears the risk of loss of the premium and a change in market value should the counterparty not perform under the contract. Put and call options purchased are accounted for in the same manner as portfolio securities. Premiums received from writing options are reported as a liability on the Statement of Assets and Liabilities. Those that expire unexercised are treated by the Company on the expiration date as realized gains on written option transactions in the Statement of Operations. The difference between the premium received and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss on written option transactions in the Statement of Operations. If a written call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the Company has realized a gain or loss on investments in the Statement of Operations. If a written put option is exercised, the premium reduces the cost basis for the securities purchased by the Company and is parenthetically disclosed on the Statement of Assets and Liabilities. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. See Note 4 for option activity.
c.Security Transactions and Investment Income Security transactions are recorded as of the trade date. Realized gains and losses are determined on the specific identification method. Dividend income and distributions to stockholders are recorded as of the ex-dividend dates. Interest income, adjusted for amortization of discount and premium on investments, is earned from settlement date and is recognized on the accrual basis. Cost of short-term investments represent amortized cost.
d.Foreign Currency Translation and Transactions Portfolio securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the exchange rate of such currencies versus U.S. dollars on the date of valuation. Purchases and sales of securities, income and expense items denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date. Events may impact the availability or reliability of foreign exchange rates used to convert the U.S. dollar equivalent value. If such an event occurs, the foreign exchange rate will be valued at fair value using procedures established and approved by the Company’s Board of Directors. The Company does not separately report the effect of changes in foreign exchange rates from changes in market prices on securities held. These changes are combined and included in net realized and unrealized gain or loss on the Statement of Operations.
12 |
|
NOTES TO FINANCIAL STATEMENTS (Unaudited) - continued |
General American Investors |
Realized foreign exchange gains or losses may also arise from sales of foreign currencies, currency gains or losses realized between the trade and settlement dates on securities transactions and the difference between the recorded amounts of dividends, interest, and foreign withholding taxes and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses may also arise from changes in foreign exchange rates on foreign currency denominated assets and liabilities other than investments in securities held at the end of the reporting period.
Foreign security and currency transactions may involve certain considerations and risks not typically associated with those of U.S. companies as a result of, among other factors, the possibility of political or economic instability or the level of governmental supervision and regulation of foreign securities markets.
e.Dividends and Distributions The Company expects to pay dividends of net investment income and distributions of net realized capital and currency gains, if any, annually to common shareholders and quarterly to preferred shareholders. Dividends and distributions to common and preferred shareholders, which are determined in accordance with Federal income tax regulations are recorded on the ex-dividend date. Permanent book/tax differences relating to income and gains are reclassified to paid-in capital as they arise.
f.Federal Income Taxes The Company’s policy is to fulfill the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all taxable income to its stockholders. Accordingly, no provision for Federal income taxes is required. In accordance with U.S. GAAP requirements regarding accounting for uncertainties in income taxes, management has analyzed the Company’s tax positions taken or expected to be taken on Federal and state income tax returns for all open tax years (the current and the prior three tax years) and has concluded that no provision for income tax is required in the Company’s financial statements.
g.Contingent Liabilities Amounts related to contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of a matter that are reasonably estimable and, if so, they are included in the accrual.
h.Indemnifications In the ordinary course of business, the Company enters into contracts that contain a variety of indemnifications. The Company’s maximum exposure under these arrangements is unknown. However, the Company has not had prior claims or losses pursuant to these indemnification provisions and expects any future risk of loss thereunder to be remote.
i.Coronavirus Pandemic The Coronavirus (COVID-19) pandemic has caused significant humanitarian and economic disruption both nationally and internationally. For the most part, governments worldwide have responded with significant fiscal and monetary stimulus to offset the decline in commercial activity. Improved treatments have been administered to those infected and multiple vaccines have been developed and are being broadly administered with the goal of achieving herd immunity and reducing the impact of the virus over time. Increased market volatility has occurred since February 2020. The Company, like many others, has adopted a telecommuting (i.e., work from home) posture in response but, otherwise continues to operate without significant adverse impact in light of the above events.
2.Fair Value Measurements – Various data inputs are used in determining the value of the Company’s investments. These inputs are summarized in a hierarchy consisting of the three broad levels listed below:
Level 1 - quoted prices in active markets for identical securities (including money market funds which are valued at net asset value, typically $1 per share),
Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, etc.), and
Level 3 - significant unobservable inputs (including assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the inputs used to value the Company’s net assets as of June 30, 2021:
1.Significant Accounting Policies and Other Matters – (Continued from bottom of previous page.)
13 |
|
NOTES TO FINANCIAL STATEMENTS (Unaudited) - continued |
General American Investors |
Assets |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Common stocks |
|
$1,281,285,133
|
|
— |
|
— |
|
$1,281,285,133
|
Rights |
|
— |
|
— |
|
— |
|
— |
Purchased options |
|
71,435 |
|
— |
|
— |
|
71,435 |
Money market fund |
|
154,810,707 |
|
— |
|
— |
|
154,810,707 |
Total |
|
$1,436,167,275
|
|
— |
|
— |
|
$1,436,167,275
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Options written |
|
$841,970
|
|
— |
|
— |
|
$841,970
|
No transfers among levels occurred during the six month ended June 30, 2021.
3.Purchases and Sales of Securities – Purchases and sales of securities (other than short-term securities and options) for the six months ended June 30, 2021 amounted to $159,426,261 and $140,185,556, on long transactions, respectively.
4.Options – The level of activity in purchased and written options varies from year-to-year based upon market conditions. Transactions in purchased call and put options, as well as written covered call options and collateralized put options during the six months ended June 30, 2021 were as follows:
Purchased Options |
|
Calls |
|
Puts |
|
||||
|
|
Contracts |
|
Cost Basis |
|
Contracts |
|
Cost Basis |
|
Outstanding, December 31, 2020 |
|
— |
|
— |
|
200 |
|
$484,675
|
|
Purchased |
|
2,805 |
|
$398,332
|
|
— |
|
— |
|
Exercised |
|
(1,623 |
) |
(315,029 |
) |
— |
|
— |
|
Expired |
|
(83 |
) |
(2,392 |
) |
(200 |
) |
(484,675 |
) |
Outstanding, June 30, 2021 |
|
1,099 |
|
$80,911
|
|
— |
|
$—
|
|
|
|
|
|
|
|
|
|
|
|
Written Options |
|
Covered Calls |
|
Collateralized Puts |
|
||||
|
|
Contracts |
|
Premiums |
|
Contracts |
|
Premiums |
|
Outstanding, December 31, 2020 |
|
200 |
|
$273,548
|
|
263 |
|
$48,156
|
|
Written |
|
8,100 |
|
1,456,789 |
|
10,567 |
|
2,108,755 |
|
Terminated in closing purchase transaction |
|
(3,500 |
) |
(540,275 |
) |
(7,735 |
) |
(1,303,454 |
) |
Assigned |
|
(200 |
) |
(273,548 |
) |
— |
|
— |
|
Expired |
|
(1,000 |
) |
(65,963 |
) |
— |
|
— |
|
Outstanding, June 30, 2021 |
|
3,600 |
|
$850,551
|
|
3,095 |
|
$853,457
|
|
5.Capital Stock and Dividend Distributions – The authorized capital stock of the Company consists of 50,000,000 shares of Common Stock, $1.00 par value, and 10,000,000 shares of Preferred Stock, $1.00 par value. With respect to the Common Stock, 24,181,874 shares were issued and outstanding; 8,000,000 Preferred Shares were originally issued and 7,604,687 were outstanding on June 30, 2021.
On September 24, 2003, the Company issued and sold 8,000,000 shares of its 5.95% Cumulative Preferred Stock, Series B in an underwritten offering. The Preferred Shares were noncallable for the 5 year period ended September 24, 2008 and have a liquidation preference of $25.00 per share plus accumulated and unpaid dividends to the date of redemption.
On December 10, 2008, the Board of Directors authorized the repurchase of up to 1 million Preferred Shares in the open market at prices below $25.00 per share. This authorization has been renewed annually thereafter. To date, 395,313 shares have been repurchased.
The Company allocates distributions from net capital gains and other types of income proportionately among holders of shares of Common Stock and Preferred Stock. To the extent that dividends on the shares of Preferred Stock are not paid from net capital gains, they will be paid from investment company taxable income, or will represent a return of capital.
Under the Investment Company Act of 1940, the Company is required to maintain an asset coverage of at least 200% of the Preferred Stock. In addition, pursuant to Moody’s Investor Service, Inc. Rating Agency Guidelines, the Company is required to maintain a certain discounted asset coverage for its portfolio that equals or exceeds a Basic Maintenance Amount. If the Company fails to meet these requirements in the future and does not cure such failure, the Company may be required to redeem, in whole or in part, shares of Preferred Stock at a redemption price of $25.00 per share plus
2.Fair Value Measurements – (Continued from bottom of previous page.)
14 |
|
NOTES TO FINANCIAL STATEMENTS (Unaudited) - continued |
General American Investors |
accumulated and unpaid dividends. In addition, failure to meet the foregoing asset coverage requirements could restrict the Company’s ability to pay dividends on shares of Common Stock and could lead to sales of portfolio securities at inopportune times.
The holders of Preferred Stock have voting rights equivalent to those of the holders of Common Stock (one vote per share) and, generally, vote together with the holders of Common Stock as a single class.
Holders of Preferred Stock will elect two members to the Company’s Board of Directors and the holders of Preferred and Common Stock, voting as a single class, will elect the remaining directors. If the Company fails to pay dividends on the Preferred Stock in an amount equal to two full years’ dividends, the holders of Preferred Stock will have the right to elect a majority of the directors. In addition, the Investment Company Act of 1940 requires that approval of the holders of a majority of any outstanding Preferred Shares, voting separately as a class, would be required to (a) adopt any plan of reorganization that would adversely affect the Preferred Stock and (b) take any action requiring a vote of security holders, including, among other things, changes in the Company’s subclassification as a closed-end investment company or changes in its fundamental investment policies.
The Company presents its Preferred Stock, for which its redemption is outside of the Company’s control, outside of the net assets applicable to Common Stock in the Statement of Assets and Liabilities.
Transactions in Common Stock during the six months ended June 30, 2021 and the year ended December 31, 2020 were as follows:
|
|
Shares |
|
Amount |
|
||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
Par value of Shares issued in payment of dividends and distributions (issued from treasury) |
|
— |
|
725,430 |
|
— |
|
$725,430
|
|
Increase in paid-in capital |
|
— |
|
— |
|
— |
|
25,988,530 |
|
Total increase |
|
— |
|
725,430 |
|
— |
|
26,713,960 |
|
Par value of Shares purchased (at an average discount from net asset value of 14.6% and 16.5%, respectively) |
|
(546,332 |
) |
(750,415 |
) |
$(546,332
|
) |
(750,415 |
) |
Decrease in paid-in capital |
|
— |
|
— |
|
(21,265,191 |
) |
(25,564,718 |
) |
Total decrease |
|
(546,332 |
) |
(750,415 |
) |
(21,811,523 |
) |
(26,315,133 |
) |
Net decrease |
|
(546,332 |
) |
(24,985 |
) |
$(21,811,523
|
) |
$398,827
|
|
At June 30, 2021, the Company held in its treasury 7,798,998 shares of Common Stock with an aggregate cost of $267,850,462.
The tax basis distributions during the year ended December 31, 2020 are as follows: ordinary distributions of $4,241,853 and net capital gains distributions of $67,658,671. As of December 31, 2020, distributable earnings on a tax basis totaled $681,564,932 consisting of $10,330,141 from undistributed net capital gains and $671,234,791 from net unrealized appreciation on investments. Reclassifications arising from permanent “book/tax” difference reflect non-tax deductible expenses during the year ended December 31, 2020. As a result, additional paid-in capital was decreased by $763,267 and total distributable earnings was increased by $763,267. Net assets were not affected by this reclassification. As of December 31, 2020, the Company had wash loss deferrals of $511,174 and straddle loss deferrals of $2,292,993.
6.Officers’ Compensation – The aggregate compensation accrued and paid by the Company during the six months ended June 30, 2021 to its officers (identified on back cover) amounted to $3,594,699.
7.Benefit Plans – The Company has funded (qualified) and unfunded (supplemental) noncontributory defined benefit pension plans that are available to its employees. The pension plans provide defined benefits based on years of service and final average salary with an offset for a portion of social security covered compensation. The components of the net periodic benefit cost (income) of the plans for the six months ended June 30, 2021 were:
Service cost |
$367,327
|
|
Interest cost |
366,573 |
|
Expected return on plan assets |
(863,050 |
) |
Amortization of recognized net actuarial loss |
322,660 |
|
Net periodic benefit cost |
$193,510
|
|
5.Capital Stock and Dividend Distributions – (Continued from bottom of previous page.)
15 |
|
NOTES TO FINANCIAL STATEMENTS (Unaudited) - continued |
General American Investors |
The Company recognizes the overfunded status of its defined benefit postretirement plan as an asset in the Statement of Assets and Liabilities and recognizes changes in funded status in the year in which the changes occur through other comprehensive income.
The Company also has funded (qualified) and unfunded (supplemental) defined contribution thrift plans that are available to its employees. The aggregate cost of such plans for the six months ended June 30, 2021 was $1,304,320. The qualified thrift plan acquired 9,600 shares in the open market of the Company’s Common Stock during the six months ended June 30, 2021 and held 517,045 shares of the Company’s Common Stock at June 30, 2021.
8.Operating Lease Commitment – The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases, which requires lessees to reassess if a contract is or contains lease agreements and assess the lease classification to determine if they should recognize a right-of-use asset and offsetting liability on the Statement of Assets and Liabilities that arises from entering into a lease, including an operating lease. The right-of-use asset and offsetting liability is reported on the Statement of Assets and Liabilities in line items entitled, “Present value of future office lease payments.” Since the operating lease does not specify an implicit rate, the right-of-use asset and liability have been calculated using a discount rate of 3.0%, which is based upon high quality corporate interest rates for a term equivalent to the lease period as of January 1, 2018. The annual cost of the operating lease continues to be reflected as an expense in the Statements of Operations and Changes in Net Assets.
In 2017, the Company entered into an operating lease agreement for office space which will expire in 2028 and provide for aggregate rental payments of approximately $6,437,500. The lease agreement contains clauses whereby the Company will receive free rent for a specified number of months and credit towards construction of office improvements and incurs escalations annually relating to operating costs and real property taxes and to annual rent charges beginning in 2023. Rental expense approximated $297,100 for the six months ended June 30, 2021. The Company has the option to extend the lease for an additional five years at market rates. As of June 30, 2021, no consideration has been given to extending this lease. Minimum rental commitments under this operating lease are approximately:
OTHER MATTERS (Unaudited)
Previous purchases of the Company’s Common and Preferred Stock are set forth in Note 5 on page 13. Prospective purchases of Common and Preferred Stock may be made at such times, at such prices, in such amounts and in such manner as the Board of Directors may deem advisable.
The policies and procedures used by the Company to determine how to vote proxies relating to portfolio securities and the Company’s proxy voting record for the twelve-month period ended June 30, 2020 are available: (1) without charge, upon request, by calling us at our toll-free telephone number (1-800-436-8401), (2) on the Company’s website at www.generalamericaninvestors.com and (3) on the Securities and Exchange Commission’s website at www.sec.gov.
On April 29, 2021, the Company submitted a CEO annual certification to the New York Stock Exchange (“NYSE”) on which the Company’s principal executive officer certified that he was not aware, as of that date, of any violation by the Company of the NYSE’s Corporate Governance listing standards. In addition, as required by Section 302 of the Sarbanes-Oxley Act of 2002 and related SEC rules, the Company’s principal executive and principal financial officer made a semi-annual certification, included in a filing with the SEC on Form N-CSR as of December 31, 2020 relating to, among other things, the Company’s disclosure controls and procedures and internal control over financial reporting, as applicable.
7.Benefit Plans – (Continued from bottom of previous page.)
GENERAL AMERICAN INVESTORS
COMPANY, INC.
SEMI-ANNUAL REPORT
June 30, 2021
A Closed-End Investment Company
listed on the New York Stock Exchange
530 FIFTH AVENUE
NEW YORK • NY 10036
212-916-8400 • 1-800-436-8401
E-mail: InvestorRelations@gainv.com
www.generalamericaninvestors.com
DIRECTORS*
Spencer Davidson, Chairman
Arthur G. Altschul, Jr. Rodney B. Berens Clara E. Del Villar John D. Gordan, III Betsy F. Gotbaum |
Rose P. Lynch Jeffrey W. Priest Savannah Sachs Henry R. Schirmer |
(*The Company is a stand-alone fund.)
OFFICERS
Jeffrey W. Priest, President and Chief Executive Officer
Anang K. Majmudar, Senior Vice-President
Andrew V. Vindigni, Senior Vice-President
Craig A. Grassi, Vice-President
Liron Kronzon, Vice-President
Sally A. Lynch, Vice-President
Eugene S. Stark, Vice-President, Administration, Principal
Financial Officer & Chief Compliance Officer
Samantha X. Jin, Treasurer
Linda J. Genid, Corporate Secretary
Connie A. Santa Maria, Assistant Corporate Secretary
SERVICE COMPANIES
Counsel Sullivan & Cromwell LLP Independent Auditors Ernst & Young LLP
Custodian and
State Street Bank and
|
Transfer Agent and Registrar
American Stock Transfer & Trust
6201 15th Avenue
|
ITEM 2. CODE OF ETHICS.
Not applicable to this semi-annual report.
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.
Not applicable to this semi-annual report.
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
Not applicable to this semi-annual report.
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.
Not applicable to this semi-annual report.
ITEM 6. SCHEDULE OF INVESTMENTS
The schedule of investments in securities of unaffiliated issuers is included as part of the report to stockholders filed under Item 1 of this form.
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable to this semi-annual report.
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable to this semi-annual report.
ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.
(a) General American Investors Company, Inc. Common Stock (GAM)
Period 2021 |
(a) Total Number
of shares (or Units) Purchased |
(b) Average Price
Paid per Share (or Unit) |
(c) Total Number of
Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs |
(d) Maximum Number
(or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs |
||||||||||||
01/01-01/31 | 117,237 | $ | 37.7936 | 117,237 | 897,424 | |||||||||||
02/01-02/28 | 85,141 | 38.4456 | 85,141 | 812,283 | ||||||||||||
03/01-03/31 | 132,464 | 39.0220 | 132,464 | 679,819 | ||||||||||||
04/01-04/30 | 118,079 | 41.6479 | 118,079 | 561,740 | ||||||||||||
05/01-05/31 | 43,122 | 42.5231 | 43,122 | 518,618 | ||||||||||||
06/01-06/30 | 50,289 | 43.4882 | 50,289 | 468,329 | ||||||||||||
Total for the period | 546,332 | 546,332 |
Note - | The Board of Directors has authorized the repurchase of the registrant’s common stock when the shares are trading at a discount from the underlying net asset value of at least 8%. This represents a continuation of the repurchase program which began in March 1995. As of the beginning of the period, January 1, 2021, there were 1,014,661 shares available for repurchase under the aforementioned extension of such authorization. As of the end of the period, June 30, 2021, there were 468,329 shares available for repurchase under this program. |
(b) General American Investors Company, Inc. Preferred Stock (GAMpB)
Period 2021 | (a) Total Number of shares (or Units) Purchased | (b) Average Price Paid per Share (or Unit) |
(c)
Total Number of
Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs |
(d)
Maximum Number
(or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs |
01/01-01/31 | — | — | 604,687 | |
02/01-02/28 | — | — | 604,687 | |
03/01-03/31 | — | — | 604,687 | |
04/01-04/30 | — | — | 604,687 | |
05/01-05/31 | — | — | 604,687 | |
06/01-06/30 | — | — | 604,687 | |
Total for period | — | — |
Note - | The Board of Directors has authorized the repurchase of the registrant's preferred stock when the shares are trading at a price not in excess of $25.00 per share. As of the beginning of the period, January 1, 2021, there were 604,687 shares available for repurchase under such authorization. As of the end of the period, June 30, 2021, there were 604,687 shares available for repurchase under this program. |
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
There have been no material changes to the procedures by which shareholders may recommend nominees to the registrant's Board of Directors as set forth in the registrant's Proxy Statement, dated February 18, 2021.
ITEM 11. CONTROLS AND PROCEDURES.
Conclusions of principal officers concerning controls and procedures
(a) As of June 30, 2021, an evaluation was performed under the supervision and with the participation of the officers of General American Investors Company, Inc. (the "Registrant"), including the principal executive officer ("PEO") and principal financial officer ("PFO"), to assess the effectiveness of the Registrant's disclosure controls and procedures. Based on that evaluation, the Registrant's officers, including the PEO and PFO, concluded that, as of June 30, 2021, the Registrant's disclosure controls and procedures were reasonably designed so as to ensure: (1) that information required to be disclosed by the Registrant on Form N-CSR is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Securities and Exchange Commission; and (2) that material information relating to the Registrant is made known to the PEO and PFO as appropriate to allow timely decisions regarding required disclosure.
(b) There have been no significant changes in the Registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940 (17 CFR 270.30a-3(d)) that occurred during the Registrant’s last fiscal period that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.
ITEM 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
ITEM 13. EXHIBITS
(a) | (1) | The code of ethics disclosure required by Item 2 is not applicable to this semi-annual report. |
(3) | Written solicitation to purchase securities is not applicable to this semi-annual report. |
(4) | Change in independent public accountant is not applicable to this semi-annual report. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
General American Investors Company, Inc. | |||
By: | /s/ Eugene S. Stark | ||
Eugene S. Stark | |||
Vice-President, Administration | |||
Date: August 5, 2021 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/ Jeffrey W. Priest | ||
Jeffrey W. Priest | |||
President and Chief Executive Officer | |||
(Principal Executive Officer) | |||
Date: August 5, 2021 | |||
By: | /s/ Eugene S. Stark | ||
Eugene S. Stark | |||
Vice-President, Administration | |||
(Principal Financial Officer) | |||
Date: August 5, 2021 |
1 Year General American Investors Chart |
1 Month General American Investors Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions